Schedule 13G ownership disclosure
NRX PHARMACEUTICALS INC
Common Stock, $0.001 par value · CUSIP: 629444209
Event date: 2025-08-18
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- The B Group, Inc.
Shares: 3,000,000.00 · Class: 12.62%
- B Group Capital LLC
Shares: 3,000,000.00 · Class: 12.62%
- Branden B. Muhl
Shares: 3,000,000.00 · Class: 12.62%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-079159
- Form type
- SCHEDULE 13G
- Filer
- B Group, Inc.
- CIK
- CIK 2043476
- Filed
- Aug 21, 2025
- Reporting period
- Aug 18, 2025
- Description
- Schedule 13G beneficial ownership